Dabur India Limited · NSE:DABUR

Dabur India — Investor Presentation (March 2013)

40 slides from Dabur India's investor presentation, March 2013

  1. Slide 1: Dabur India Limited Corporate Profile March 2013

    Dabur India Limited Corporate Profile March 2013 1 1

  2. Slide 2: Agenda

    Agenda Dabur India-Introduction FMCG Industry Scenario Business Overview Growth Strategy Recent Performance 2 2

  3. Slide 3: Dabur India: Overview

    Dabur India: Overview 9 Established E t bli h d iin 1884 - more than th 125 Twelve l Billion illi Rupee Brands d Years of Trust & Excellence 9 Among top 4 FMCG companies in India 9 g World’s largest in Ayurveda y and natural healthcare 9 Revenue of Rs. 53.2 billion and profits of Rs. 6.4 billion in

  4. Slide 4: Dabur: Vision and Core Values

    Dabur: Vision and Core Values Vision •Dedicated to the health and well being of every household Ownership Passion for Integrity Winning Core Values People Innovation Development Consumer Team Work Focus 4 4

  5. Slide 5: Key Milestones

    Key Milestones 1884 1972 1986 •Dr. SK Burman •The company •Registered as started an Ayurvedic shifted base to Public Limited Pharmacy in Kolkatta Delhi from Kolkata Company 1994 1998 2003 •Listed on the •Professionalized with •Pharmaceutical Business B Bombay b Stock St k B Burman Family F il handin

  6. Slide 6: Performance at a Glance (5 years)

    Performance at a Glance (5 years) Net Sales Sales (Rs. billion) Net Profit (Rs. billion) 6.5 52.8 5.7 5.0 40.8 33.9 3.9 28.1 3.3 23.6 FY08 FY09 FY10 FY11 FY12 FY08 FY09 FY10 FY11 FY12 EBITDA (Rs. (R billion) billi ) Sh Shareholders h ld F Funds d (R (Rs. billion) billi ) 9.5 8.3 17.2 6.7 13.9 5.2 4.

  7. Slide 7: Global Footprint

    {Global Footprint ad > a . - a

  8. Slide 8: Distribution Overview

    Distribution Overview Factory (Carry & Forward Agents) Depot Stockists Super stockists Insti Stockists Modern Trade Military / CSD Stockist Wholesalers Sub stockists Retail trade Rural trade Unit Canteens Insti customers Direct reach Shoppers & Consumers 0.8 mn outlets 3rd largest distribution netwo

  9. Slide 9: Research & Development Focus

    Research & Development Focus Team of scientists including Strong New Product Development Ayurvedic doctors, Pharmacists, Agronomists, Botanists, Tissue 9 Ayurvedic Medicines Culture specialists, etc. 9 Personal Care 9 Foods 9 Home Care Agro Biotech Initiatives 9 OTC Healthcare 9 Protecting endangere

  10. Slide 10: Agenda

    Agenda Dabur India-Introduction FMCG Industry Scenario Business Overview Growth Strategy Recent Performance 10 10

  11. Slide 11: FMCG Industry Snapshot

    FMCG Industry Snapshot FMCG Industry Size (in Rs. bn) FMCG Industry Urban (in Rs. bn) FMCG Industry Rural (in Rs. bn) 2,500 800 2,000 1 895 1,895 1 400 1,400 1 262 1,262 700 633 1,626 1,200 1,082 600 544 1,500 1,000 500 800 400 1,000 600 300 500 400 200 200 100 0 0 0 MAT Sep '11 MAT Sep '12 MAT Sep

  12. Slide 12: Penetration Levels: Sufficient Headroom

    Penetration Levels: Sufficient Headroom Rural Penetration Urban Penetration 90% 80% 80% 77% 70% 67% 57% 59% 60% 50% 42% 40% 37% 32% 30% 26% 18% 18% 19% 20% 10% 3% 5% 4% 2% 0% Toothpaste Shampoo Hair Oil Skin Cream Mosquito Instant Hair Dyes Floor Cleaners Repellants Noodles Source: Industry data 9 L

  13. Slide 13: Per Capita Consumption: Room for Growth

    Per Capita Consumption: Room for Growth India has low per capita consumption as compared to other emerging economies Skin Care – Per Capita Consumption (in US$) Shampoo – Per Capita Consumption (in US$) in US$ in US$ 9 3 27 2.7 7.4 77 7.7 8 2.5 2.4 7 6 2 5 1.5 4 3.2 1.0 1.1 3 1 2 0.8 0.5 0.3 1 0.3 0

  14. Slide 14: Key Players: FMCG

    Key Players: FMCG in Rs. Rs million Company Key Categories Sales Profit Market Cap Soaps, Detergents, Hindustan Unilever Ltd 229,877 , 27,907 , 975,094 , Personal Care, Care Foods Food, Beverages, Infant Nestle India Ltd* 83,023 10,679 455,564 nutrition Health Care,, Personal Dabur India Ltd 52 832

  15. Slide 15: Dabur: Strong Presence in FMCG Categories

    Dabur: Strong Presence in FMCG Categories Category Position Market Share Key Brands Dabur Amla hair Oil, Vatika hair oil & Hair Care 3 12% Vatika Shampoos Red toothpaste, Babool, Meswak, Red Oral Care 3 13% toothpowder Ayurvedic 1 67% Dabur Chyawanprash Tonics Digestives 1 56% Hajmola Fruit Juices 1

  16. Slide 16: Agenda

    Agenda Dabur India-Introduction FMCG Industry Scenario Business Overview Growth Strategy Recent Performance 16 16

  17. Slide 17: Business Structure

    Business Structure Dabur India Limited Domestic Business International (69.7%) Business (30.3%) Consumer Dabur Hobi Namaste Foods Retail Others* Care International Group Labs. LLC (10.1%) ( ) (0.8%) ( ) (2.7%) ( ) (56 0%) (56.0%) (17 5%) (17.5%) (2 6%) (2.6%) (10 3%) (10.3%) Note: % figure in bracke

  18. Slide 18: Consumer Care Overview

    Consumer Care Overview Category-wise Share of Consumer Care Sales Health Oral Care Supplements 17% 21% Skin Care 6% Digestives Home Care 8% 6% OTC & Ethicals Hair Care 12% 30% 9 Hair Care is the largest category and contributes to 29% of Consumer Care sales 9 Health Supplements contribute to 22% of

  19. Slide 19: Consumer Care Categories

    Consumer Care Categories Hair Oils Key Brands #2 player in Hair Oils Dabur Amla: Vatika: Value added Almond Hair Oil Largest brand in coconut oil the portfolio Shampoo Key Brands #4 player in Shampoos Vatika range of shampoos 19 19

  20. Slide 20: Consumer Care Categories

    Consumer Care Categories Oral Care Key Brands #3 player in Toothpastes #2 player in Meswak: Premium Toothpowder Dabur Red: Toothpaste Babool: Targeted at therapeutic & Toothpowder economy segment toothpaste Skin Care Key Brands #1 player l in i Skin Care (Bleaches) Gulabari G l b i range off Uveda:

  21. Slide 21: Consumer Care Categories

    Consumer Care Categories Home Care Key Brands #1 player in Air Fresheners #1 p player y in Mosquito Repellant Creams Odonil: Air freshner Odomos: Mosquito Sanifresh: #2 player l in i Toilet T il t range: Largest L t brand b d repellant ll t skin ki cream Toilet cleaner in the portfolio Cleaners 9Odo

  22. Slide 22: Consumer Care Categories

    Consumer Care Categories H lth Supplements Health S l t Key Brands #1 player in Ayurvedic y Tonics #2 player in Glucose Dabur Chyawanprash: Dabur Glucose: Dabur Honey: Largest #1 player in Largest selling health 2nd largest branded honey in the supplement in the player in the country branded Honey c

  23. Slide 23: Consumer Care Categories

    Consumer Care Categories OTC and d Ethicals Ethi l 9 Repository of Dabur’s Ayurvedic Healthcare knowledge 9 Range of over 260 products 9 Focusing on multiple therapeutic areas 9 Focus on growing the OTC Health-Care portfolio aggressively Key OTC Brands Lal Tail Honitus Janma Ghunti Dashmularishta As

  24. Slide 24: Foods Business

    Foods Business 9 Foods portfolio comprises Juices and Culinary range 9 Juices are under the brands – Real, Activ and Burrst 9 Culinary range is under Hommade brand 9 Foods business has surpassed the Rs. 5 billion mark in sales Foods Key Brands #1 player in Fruit Juices Real: R l Fl Flagship hi Real

  25. Slide 25: International Business

    International Business ƒ Started as an ƒ Set up a franchisee at ƒ Renamed franchisee as Dabur ƒ Building scale scale- c. c 30% of Exporter Dubai in 1989 International Ltd Consol. Sales ƒ Focus on Order ƒ Demand generation ƒ Local operations further strengthened ƒ High Levels of Localization fulfillm

  26. Slide 26: Africa and Middle East Overview

    Africa and Middle East Overview Real GDP Growth Rates (YoY) in % Africa’s Bulging Base Source: IMF Source: McKinsey on Africa, June 2010 9 Middle East and Africa have witnessed stable GDP growth rates 9 Between 2005 and 2015, it is estimated that in Africa, the share of individuals earning above US$

  27. Slide 27: Acquisition of Hobi Group, Turkey

    Acquisition of Hobi Group, Turkey 9 Acquisition of Hobi Group, Turkey for a total consideration of US$ 69 Million completed on October 7, 2010 9 Hobi manufactures and markets hair, skin and body care products under the brands Hobby and New Era 9 Product range of the company is complementary to our p

  28. Slide 28: Acquisition of Namaste Laboratories

    Acquisition of Namaste Laboratories 9 Dabur India Limited through its subsidiary Dabur International Limited acquired 100% stake in Namaste Laboratories LLC for $100 million, in an all-cash deal on January 1, 2011 9 Namasté is a leading ethnic hair care products company, having products for women of

  29. Slide 29: Agenda

    Agenda Dabur India-Introduction FMCG Industry Scenario Business Overview Growth Strategy Recent Performance 29 29

  30. Slide 30: Growth Strategy

    Growth Strategy Three pronged Growth Strategy Expand Innovate Acquire Our differentiation is the herbal and ayurvedic platform Expand 9 Strengthening presence in existing categories and markets as well entering new geographies 9 Maintain dominant share in categories where we are category builders li

  31. Slide 31: Recent Launches - India

    Recent Launches - India Babool: Salt Variant Thirty Plus Activ: Banana Strawberry and Green Apple Punch Variants Odonil Gels Gulabari: Saffron & Turmeric Cold Cream Gulabari: Moisturizing Lotion Fem: Saffron and Pearl Variants 31 31 31

  32. Slide 32: Recent Launches - International

    Recent Launches - International Vatika Enriched Vatika Henna Hair Dabur – Medicated Vatika Hair Oil – Black Color Toothpaste Professional Seed Rangeg Curls Unleashed Range 32 32 32

  33. Slide 33: Agenda

    Agenda Dabur India-Introduction FMCG Industry Scenario Business Overview Growth Strategy Recent Performance 33 33

  34. Slide 34: Recent Financial Performance

    Recent Financial Performance ¾ Consolidated Sales grew by 17.7% during 9MFY13 Revenue ¾ Sales growth was a combination of volume (in Rs. Cr.) growth, price increases and translation gains ¾ EBITDA increased by 17.6% 17 6% and EBITDA margin was steady at 18.0% in 9MFY13 EBITDA ¾ Material costs eased,

  35. Slide 35: Market Cap & Shareholding

    Market Cap & Shareholding Market Cap (Rs. Million) Shareholding Structure* 231,800 Others, DIIs, 5.1% 6.6% FIIs 19 FIIs, 19.6% 6% 137,997 Promoters, 22,403 31,760 68.7% Mar‐2000 Mar‐2005 Mar‐2010 Feb‐2013 *As of Dec 31, 2012 ¾ Dabur has witnessed exponential increase in market capitalization over th

  36. Slide 36: Consolidated P&L

    Consolidated P&L IIn Rs. R mn Q3FY13 Q3FY12 YoY Y Y (%) 9MFY13 9MFY12 YoY Y Y (%) Net Sales 16,307.2 14,526.8 12.3% 46,152.9 39,195.9 17.7% Other Operating Income 52.6 46.0 171.8 139.7 Material Cost 7,953.6 7,404.0 7.4% 22,794.7 20,075.1 13.5% % of Sales 48.8% 51.0% 49.4% 51.2% Employee Costs 1,229.

  37. Slide 37: Consolidated Statement of Assets and Liabilities

    Consolidated Statement of Assets and Liabilities Dabur India Limited Consolidated Statement of Assets and Liabilities (Amount in Rs Rs.mn) mn) Particulars As at 31/12/2012 (Unaudited) As at 31/03/2012 (Audited) Â EQUITY AND LIABILITIES 1 Shareholders’ funds (a) Share capital 1,743 1,742 (b) Reserves

  38. Slide 38: Recent Accolades

    Recent Accolades Dabur has been voted by Dabur has been ranked Dabur ranked as No. Dabur India Ltd has been consumers as Indian as the Most Trusted 2 Most Social Brand ranked among the Top 10 P PowerBrand B d 2011-2012 2011 2012 L d in Leader i the th Healthcare H lth of India, India in the Social ‘

  39. Slide 39: Disclaimer

    Disclaimer Some of the statements made in this presentation contain forward looking information that involve a number of risks and uncertainties. uncertainties Such statements are based on a number of assumptions, assumptions estimates, estimates projections or plans that are inherently subject to s

  40. Slide 40: Investor Relations

    Investor Relations Dabur India Ltd Contact:+91-11-42786000 40 40

Dabur India — Investor Presentation (March 2013) on 6ix